Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07525258 · ClinicalTrials.gov registry record · NA
Implementation Facilitation Pilot for Alcohol Use Disorder (AUD) in Alcohol-associated Liver Disease (ALD)
A NA study, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT07525258 is a NA study that is actively recruiting participants, run by Yale University. The registered enrollment target is 30 participants.
The verdict
NCT07525258, a NA study, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The goal of this project is to improve provision of integrated medications for alcohol use disorder (MAUD) with brief counseling for patients with alcohol use disorder (AUD) and alcohol-associated liver disease (ALD) in hepatology clinics. There are many benefits of AUD treatment among patients with AUD and ALD such as reduction in liver-related complications and hepatology clinicians providing this care in an integrated fashion can improve access and uptake.
Interventions
- BEHAVIORAL Implementation Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-04-05 |
| Est. Completion | 2029-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07525258
The ClinicalTrials.gov registry entry for NCT07525258 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Implementation Intervention is the first listed.
NCT07525258 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07525258 about?
NCT07525258 is a clinical study titled "Implementation Facilitation Pilot for Alcohol Use Disorder (AUD) in Alcohol-associated Liver Disease (ALD)". The goal of this project is to improve provision of integrated medications for alcohol use disorder (MAUD) with brief counseling for patients with alcohol use disorder (AUD) and alcohol-associated liver disease (ALD) in hepatology clinics. There are many benefits of AUD treatment among patients with...
What is the current status of trial NCT07525258?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-04-05. Estimated completion is 2029-04.
What interventions are being tested in trial NCT07525258?
The interventions under investigation include: Implementation Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07525258?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.